1. Home
  2. LPCN vs HUDI Comparison

LPCN vs HUDI Comparison

Compare LPCN & HUDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • HUDI
  • Stock Information
  • Founded
  • LPCN 1997
  • HUDI 1998
  • Country
  • LPCN United States
  • HUDI China
  • Employees
  • LPCN N/A
  • HUDI N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • HUDI Steel/Iron Ore
  • Sector
  • LPCN Health Care
  • HUDI Industrials
  • Exchange
  • LPCN Nasdaq
  • HUDI Nasdaq
  • Market Cap
  • LPCN 16.1M
  • HUDI 19.1M
  • IPO Year
  • LPCN N/A
  • HUDI 2021
  • Fundamental
  • Price
  • LPCN $3.00
  • HUDI $1.30
  • Analyst Decision
  • LPCN Strong Buy
  • HUDI
  • Analyst Count
  • LPCN 2
  • HUDI 0
  • Target Price
  • LPCN $9.00
  • HUDI N/A
  • AVG Volume (30 Days)
  • LPCN 29.3K
  • HUDI 13.7K
  • Earning Date
  • LPCN 08-07-2025
  • HUDI 08-05-2025
  • Dividend Yield
  • LPCN N/A
  • HUDI N/A
  • EPS Growth
  • LPCN N/A
  • HUDI N/A
  • EPS
  • LPCN N/A
  • HUDI 0.01
  • Revenue
  • LPCN $3,674,834.00
  • HUDI $74,270,429.00
  • Revenue This Year
  • LPCN N/A
  • HUDI N/A
  • Revenue Next Year
  • LPCN N/A
  • HUDI N/A
  • P/E Ratio
  • LPCN N/A
  • HUDI $132.90
  • Revenue Growth
  • LPCN N/A
  • HUDI N/A
  • 52 Week Low
  • LPCN $2.68
  • HUDI $1.26
  • 52 Week High
  • LPCN $7.61
  • HUDI $3.45
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 40.07
  • HUDI 41.63
  • Support Level
  • LPCN $3.10
  • HUDI $1.26
  • Resistance Level
  • LPCN $3.39
  • HUDI $1.40
  • Average True Range (ATR)
  • LPCN 0.18
  • HUDI 0.05
  • MACD
  • LPCN -0.00
  • HUDI -0.00
  • Stochastic Oscillator
  • LPCN 0.00
  • HUDI 37.00

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

Share on Social Networks: